Tracked deals
5
5 tracked deals across 2022-2025.
Waltham, Massachusetts, United States
MedEquity Capital is a private equity firm that invests in small and lower-middle-market healthcare businesses. It targets profitable companies with strong cash flow and works with management teams to pursue organic and acquisitive growth potential. Healthcare sectors of interest include provider-based services, specialty pharmacy, outsourcing, distribution, technology-enabled services, and certain low-technology-risk product companies.
Tracked deals
5
5 tracked deals across 2022-2025.
Recent pace
1
1 tracked deal announced in the last 12 months.
Deal mix
Addon
4 addon · 1 growth capital
Last 3 years
Supporting Data
MAX Surgical Specialty Management announced a partnership with New York Oral & Maxillofacial Surgery and Dental Implant Center (Drs. Mark Stein and David Koslovsky) to expand the surgeon-led MSO into New York City. The move extends MAX’s geographic footprint and network; MAX is backed by MedEquity Capital, RF Investment Partners, and Kian Capital.
MAX Surgical Specialty Management (MAX), a surgeon-led MSO backed by MedEquity Capital, RF Investment Partners, and Kian Capital, announced partnerships with Greater Philadelphia Oral Surgery and Lebanon & Lancaster Oral Surgery Group, expanding its Pennsylvania footprint. The transactions add two clinical partners (bringing MAX to four oral surgery groups / six practices in Pennsylvania) as part of the platform’s regional growth strategy.
MAX Surgical Specialty Management — a surgeon-led OMS management platform backed by MedEquity Capital, RF Investment Partners and Kian Capital — announced new partnerships with New England Oral Surgery (Vermont), Simpson Oral and Maxillofacial Surgery (Nanuet, New York) and Fairfield Oral Surgery (Fairfield, Connecticut). The additions expand MAX’s network to 25 locations across five Northeastern states as the platform pursues add-on growth and geographic expansion across the region.
RF Investment Partners and MedEquity Capital-backed MAX Surgical Specialty Management completed four add-on acquisitions to expand its physician-led oral and maxillofacial surgery platform into New York, Pennsylvania and Vermont. The transactions increase MAX's scale as it targets ~100% growth in 2024 and now supports 28 surgeons across 21 locations in four states.
RF Investment Partners led a strategic investment alongside MedEquity Capital and Kian Capital Partners to form Riverside Oral Surgery Management, LLC in partnership with Riverside Oral Surgery, LLC. The investment creates a physician-led multisite oral and maxillofacial surgery platform based in River Edge, New Jersey, intended to support affiliation growth, clinical autonomy for surgeons, and expansion across the Northeast.
Turn tracked acquisition activity into an outreach-ready buyer list.